Millennium Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.6M | Sell |
389,900
-160,800
| -29% | -$9.37M | 0.01% | 1421 |
|
|
2025
Q4 | $29.7M | Sell |
550,700
-240,400
| -30% | -$11.6M | 0.01% | 1198 |
|
|
2025
Q3 | $35.7M | Buy |
791,100
+301,800
| +62% | +$14.1M | 0.02% | 1114 |
|
|
2025
Q2 | $22.6M | Buy |
489,300
+79,100
| +19% | +$3.88M | 0.01% | 1454 |
|
|
2025
Q1 | $25M | Sell |
410,200
-70,600
| -15% | -$4.12M | 0.01% | 1313 |
|
|
2024
Q4 | $27.2M | Sell |
480,800
-213,000
| -31% | -$11.9M | 0.01% | 1266 |
|
|
2024
Q3 | $35.9M | Buy |
693,800
+83,100
| +14% | +$3.9M | 0.02% | 1060 |
|
|
2024
Q2 | $25.4M | Buy |
610,700
+19,500
| +3% | +$873K | 0.01% | 1294 |
|
|
2024
Q1 | $32.1M | Sell |
591,200
-165,700
| -22% | -$8.44M | 0.01% | 1149 |
|
|
2023
Q4 | $38.8M | Sell |
756,900
-2,873,300
| -79% | -$151M | 0.02% | 976 |
|
|
2023
Q3 | $211M | Buy |
3,630,200
+2,606,100
| +254% | +$160M | 0.11% | 134 |
|
|
2023
Q2 | $65.5M | Sell |
1,024,100
-1,048,400
| -51% | -$70.3M | 0.03% | 570 |
|
|
2023
Q1 | $144M | Sell |
2,072,500
-595,400
| -22% | -$42M | 0.08% | 198 |
|
|
2022
Q4 | $192M | Buy |
2,667,900
+1,170,500
| +78% | +$88.3M | 0.11% | 147 |
|
|
2022
Q3 | $106M | Buy |
1,497,400
+662,600
| +79% | +$48.1M | 0.06% | 295 |
|
|
2022
Q2 | $64.3M | Buy |
834,800
+191,200
| +30% | +$14.6M | 0.04% | 503 |
|
|
2022
Q1 | $47M | Buy |
643,600
+255,700
| +66% | +$17.2M | 0.02% | 733 |
|
|
2021
Q4 | $24.2M | Sell |
387,900
-578,700
| -60% | -$33.9M | 0.01% | 1280 |
|
|
2021
Q3 | $57.2M | Sell |
966,600
-250,800
| -21% | -$16.5M | 0.03% | 574 |
|
|
2021
Q2 | $81.3M | Buy |
1,217,400
+79,700
| +7% | +$5.2M | 0.05% | 388 |
|
|
2021
Q1 | $71.8M | Buy |
1,137,700
+296,000
| +35% | +$18.4M | 0.05% | 347 |
|
|
2020
Q4 | $52.2M | Sell |
841,700
-1,592,800
| -65% | -$97.9M | 0.04% | 438 |
|
|
2020
Q3 | $139K | Buy |
2,434,500
+519,700
| +27% | +$31.3M | 0.17% | 78 |
|
|
2020
Q2 | $105M | Buy |
1,914,800
+1,305,200
| +214% | +$78.1M | 0.14% | 101 |
|
|
2020
Q1 | $30.1M | Sell |
609,600
-235,100
| -28% | -$14.4M | 0.07% | 300 |
|
|
2019
Q4 | $39.4M | Buy |
844,700
+900
| +0.1% | +$51.5K | 0.05% | 481 |
|
|
2019
Q3 | $42.8M | Buy |
843,800
+43,800
| +5% | +$2.06M | 0.07% | 363 |
|
|
2019
Q2 | $36.3M | Buy |
800,000
+581,300
| +266% | +$27.1M | 0.05% | 471 |
|
|
2019
Q1 | $10.4M | Buy |
218,700
+68,700
| +46% | +$3.42M | 0.02% | 1213 |
|
|
2018
Q4 | $7.8M | Sell |
150,000
-50,000
| -25% | -$2.69M | 0.01% | 1281 |
|
|
2018
Q3 | $12.4M | Buy |
200,000
+125,000
| +167% | +$7.42M | 0.02% | 1152 |
|
|
2018
Q2 | $4.15M | Sell |
75,000
-325,000
| -81% | -$17.6M | 0.01% | 1925 |
|
|
2018
Q1 | $25.3M | Buy |
400,000
+225,000
| +129% | +$14.5M | 0.03% | 755 |
|
|
2017
Q4 | $10.7M | Buy |
+175,000
| New | +$10.9M | 0.01% | 1288 |
|
|
2017
Q3 | – | Sell |
-375,000
| Closed | -$20.9M | – | 3515 |
|
|
2017
Q2 | $20.9M | Buy |
+375,000
| New | +$20.4M | 0.04% | 653 |
|
|
2017
Q1 | – | Sell |
-500,000
| Closed | -$29.2M | – | 3496 |
|
|
2016
Q4 | $29.2M | Buy |
500,000
+420,000
| +525% | +$23M | 0.06% | 450 |
|
|
2016
Q3 | $4.31M | Buy |
+80,000
| New | +$5.14M | 0.01% | 1426 |
|
|
2015
Q4 | – | Sell |
-150,000
| Closed | -$8.88M | – | 3423 |
|
|
2015
Q3 | $8.88M | Sell |
150,000
-300,000
| -67% | -$19M | 0.02% | 1001 |
|
|
2015
Q2 | $29.9M | Buy |
+450,000
| New | +$29.7M | 0.06% | 440 |
|
|
2015
Q1 | – | Sell |
-105,800
| Closed | -$6.25M | – | 3585 |
|
|
2014
Q4 | $6.25M | Sell |
105,800
-1,617,900
| -94% | -$91.2M | 0.01% | 1239 |
|
|
2014
Q3 | $88.2M | Buy |
1,723,700
+678,300
| +65% | +$33.9M | 0.22% | 67 |
|
|
2014
Q2 | $50.7M | Buy |
1,045,400
+389,700
| +59% | +$19.2M | 0.14% | 141 |
|
|
2014
Q1 | $34.1M | Sell |
655,700
-397,000
| -38% | -$21.1M | 0.1% | 245 |
|
|
2013
Q4 | $56M | Buy |
1,052,700
+810,900
| +335% | +$41.3M | 0.18% | 101 |
|
|
2013
Q3 | $11.2M | Buy |
+241,800
| New | +$10.6M | 0.04% | 620 |
|
Other funds holding BMY
VCM
VPM
Millennium Management's BMY Position: Q1 2026 in Review
Millennium Management increased its Bristol-Myers Squibb (BMY) stake by 780% in Q1 2026, buying an estimated $338M and bringing the position to 6,545,442 shares worth $397M. The position accounts for 0.17% of the portfolio, ranked #93.
Millennium Management first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $480M in Q4 2024. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Millennium Management held 6,545,442 shares of Bristol-Myers Squibb worth $397M as of Q1 2026.
- Millennium Management bought 5,801,783 Bristol-Myers Squibb shares in Q1 2026, an estimated $338M.
- Bristol-Myers Squibb made up 0.17% of Millennium Management's portfolio in Q1 2026, its #93 holding.
- Millennium Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- Millennium Management's Bristol-Myers Squibb position peaked at $480M in Q4 2024.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.